Tag: HCWAINWRIGHT
NFL BIOSCIENCES: PARTICIPATION IN THE HCWAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE – 06/24/2022 at 18:00
NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of dependencies and addictions, announces that Ignacio Faus, CEO of NFL Biosciences…